Common pain relief drug may improve skin cancer tretment

Researchers from Ohio State University found that a common pain relief medication seems to increase the effectiveness of a drug used to treat skin cancer. Experiments in mice showed that the combination of celecoxib — a prescription-only non-steroidal anti-inflammatory drug (NSAID) — and a cream commonly used to treat nonmelanoma skin cancer was up to 35 percent more effective in reducing the number of skin cancer tumors than treating such lesions with the cream alone.